Clinical Trial Details
| Trial ID: | L2822 |
| Source ID: | NCT04513704 |
| Associated Drug: | Oral Semaglutide |
| Title: | A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Healthy Volunteers Type 2 Diabetes |
| Interventions: | DRUG: Oral Semaglutide |
| Outcome Measures: | Primary: Area under the semaglutide plasma concentration - time curve during a dosing interval after the 10th dosing (AUC0-24h,sema,day10), nmol\*h/L, From 0 to 24 hours after the 10th dosing (day 10) | Secondary: Maximum observed semaglutide plasma concentration after the 10th dosing (Cmax,0-24h,sema,day10), nmol/L, From 0 to 24 hours after the 10th dosing (day 10)|Time to maximum observed semaglutide plasma concentration after the 10th dosing (tmax,0-24h,sema,day10), hours (h), From 0 to 24 hours after the 10th dosing (day 10) |
| Sponsor/Collaborators: | Sponsor: Novo Nordisk A/S |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 156 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2020-08-28 |
| Completion Date: | 2021-05-26 |
| Results First Posted: | |
| Last Update Posted: | 2023-05-12 |
| Locations: | Novo Nordisk Investigational Site, Harrow, HA1 3UJ, United Kingdom |
| URL: | https://clinicaltrials.gov/show/NCT04513704 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|